IP Library Granted Patent US 9,220,683
Granted Patent B2
US 9,220,683 · App. 13/128,253 · Granted Dec 29, 2015

Lipids and compositions for the delivery of therapeutics

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,220,683
App. No.
13/128,253
Granted
Dec 29, 2015
Kind
B2
Abstract

The present invention provides lipids that are advantageously used in lipid particles for the in vivo delivery of therapeutic agents to cells. In particular, the invention provides lipids having the following structures: (Formula (I) or (XXXV)).

Claims (25)

1. A lipid of formula I

or a salt or isomer thereof, wherein

R 1 and R 2 are each independently for each occurrence optionally substituted C 10 -C 20 alkyl, optionally substituted C 10 -C 20 alkenyl, or optionally substituted C 10 -C 20 alkynyl;

R 3 is independently for each occurrence H, optionally substituted C 1 -C 10 alkyl, optionally substituted alkylheterocycle, optionally substituted heterocyclealkyl, optionally substituted amino, optionally substituted alkylamino, optionally substituted di(alkyl)amino, optionally substituted aminoalkyl, optionally substituted alkylaminoalkyl, or optionally substituted di(alkyl)aminoalkyl;

X and Y are each independently —O— or alkylene;

A 1 and A 2 are each independently —O— or —CH 2 —;

Z is N, or C(R 3 ); and

m and n are each independently 0 to 5, where m and n taken together result in a 5, 6, or 7 member ring.

2. A lipid selected from

and salts thereof.

3. A lipid particle comprising a lipid of claim 2 .

4. The lipid particle of claim 3 , wherein the particle further comprises a neutral lipid and a lipid capable of reducing aggregation.

5. The lipid particle of claim 3 , wherein the particle further comprising a therapeutic nucleic acid.

6. The lipid particle of claim 5 , wherein the nucleic acid is an siRNA.

7. A pharmaceutical composition comprising a lipid particle of claim 5 and a pharmaceutically acceptable excipient, carrier, or diluent.

8. A method of modulating the expression of a target gene in a cell, comprising providing to a cell the lipid particle of claim 6 .

9. The lipid of claim 1 , wherein R 1 and R 2 are each independently for each occurrence optionally substituted C 10 -C 20 alkyl.

10. The lipid of claim 1 , wherein R 1 and R 2 are each independently for each occurrence optionally substituted C 10 -C 20 alkenyl.

11. The lipid of claim 1 , wherein R 1 and R 2 are each independently for each occurrence optionally substituted C 10 -C 20 alkynyl.

12. The lipid of claim 1 , wherein X and Y are each independently —O—.

13. The lipid of claim 1 , wherein X and Y are each independently alkylene.

14. The lipid of claim 1 , wherein A 1 , and A 2 are each independently —O—.

15. The lipid of claim 1 , wherein A 1 , and A 2 are each independently —CH 2 —.

16. The lipid of claim 1 , wherein Z is N.

17. The lipid of claim 1 , wherein Z is C(R 3 ).

Assignments (4)
MERGER AND CHANGE OF NAME Recorded Jul 27, 2018
From: PROTIVA BIOTHERAPEUTICS INC.; ARBUTUS BIOPHARMA CORPORATION
To: ARBUTUS BIOPHARMA CORPORATION
Reel/Frame 046640/0764 →
CHANGE OF NAME Recorded Mar 17, 2017
From: TEKMIRA PHARMACEUTICALS CORPORATION
To: ARBUTUS BIOPHARMA CORPORATION
Reel/Frame 041625/0448 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 21, 2013
From: ALNYLAM PHARMACEUTICALS, INC.
To: TEKMIRA PHARMACEUTICALS CORPORATION
Reel/Frame 029852/0306 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 2, 2011
From: MANOHARAN, MUTHIAH; RAJEEV, KALLANTHOTTATHIL G.; BUTLER, DAVID; NARAYANANNAIR, JAYAPRAKASH K.; JAYARAMAN, MUTHUSAMY; ELTEPU, LAXMAN
To: ALNYLAM PHARMACEUTICALS, INC.
Reel/Frame 026850/0313 →